Active Pharmaceutical Ingredient (API) Market (By Type of Synthesis: Biotech [Monoclonal antibodies, Recombinant proteins, Vaccines], Synthetic; By Type of Manufacturer: Captive APIs, Merchant APIs; By Type: Innovative APIs, Generic APIs; By Application: Cardiology [Generic, Innovative], Orthopedic [Generic, Innovative], Oncology [Generic, Innovative], Endocrinology [Generic, Innovative], Pulmonology [Generic, Innovative], Gastroenterology [Generic, Innovative], CNS & Neurology[Generic, Innovative], Nephrology [Generic, Innovative], Ophthalmology [Generic, Innovative], Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Active Pharmaceutical Ingredient (API)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Active Pharmaceutical Ingredient (API) Market By Type of Synthesis
1.2.2.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type of Synthesis (2015-2026)
1.2.2.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type of Synthesis in 2017
1.2.2.3. Biotech
1.2.2.3.1. Monoclonal antibodies
1.2.2.3.2. Recombinant proteins
1.2.2.3.3. Vaccines
1.2.2.4. Synthetic
1.2.3. Active Pharmaceutical Ingredient (API) Market By Type of Manufacturer
1.2.3.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type of Manufacturer (2015-2026)
1.2.3.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type of Manufacturer in 2017
1.2.3.3. Captive APIs
1.2.3.4. Merchant APIs
1.2.4. Active Pharmaceutical Ingredient (API) Market By Type
1.2.4.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.4.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type in 2017
1.2.4.3. Innovative APIs
1.2.4.4. Generic APIs
1.2.5. Active Pharmaceutical Ingredient (API) Market By Application
1.2.5.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.5.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Application in 2017
1.2.5.3. Cardiology
1.2.5.4. Orthopedic
1.2.5.5. Oncology
1.2.5.6. Endocrinology
1.2.5.7. Pulmonology
1.2.5.8. Gastroenterology
1.2.5.9. CNS & Neurology
1.2.5.10. Nephrology
1.2.5.11. Ophthalmology
1.2.5.12. Others
1.2.6. Active Pharmaceutical Ingredient (API) Market by Geography
1.2.6.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
CHAPTER 4. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF SYNTHESIS
4.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type of Synthesis
4.2. Biotech
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Monoclonal antibodies
4.2.4. Recombinant proteins
4.2.5. Vaccines
4.3. Synthetic
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF MANUFACTURER
5.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type of Manufacturer
5.2. Captive APIs
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Merchant APIs
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE
6.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type
6.2. Innovative APIs
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Generic APIs
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY APPLICATION
7.1. Global Active Pharmaceutical Ingredient (API) Revenue By Application
7.2. Cardiology
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.2.3. Generic
7.2.4. Innovative
7.3. Orthopedic
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3.3. Generic
7.3.4. Innovative
7.4. Oncology
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4.3. Generic
7.4.4. Innovative
7.5. Endocrinology
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5.3. Generic
7.5.4. Innovative
7.6. Pulmonology
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6.3. Generic
7.6.4. Innovative
7.7. Gastroenterology
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7.3. Generic
7.7.4. Innovative
7.8. Others
7.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8. NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
8.1. North America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Active Pharmaceutical Ingredient (API) Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
8.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9. EUROPE ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
9.1. Europe Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
10.1. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11. LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
11.1. Latin America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 12. MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
12.1. Middle East Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 13. AFRICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
13.1. Africa Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
13.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
13.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
13.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
13.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
13.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
13.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 14. COMPANY PROFILE
14.1. AbbVie Inc.
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Merck & Co., Inc.
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Boehringer Ingelheim International GmbH
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Teva Pharmaceutical Industries Ltd; Cipla, Inc.
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Albemarle Corporation
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Bristol-Myers Squibb Company
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Sun Pharmaceutical Industries Ltd.
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Mylan N.V.
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Aurobindo Pharma
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Dr. Reddy’s Laboratories Ltd.
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope


Cart Summary